129 related articles for article (PubMed ID: 25369354)
1. Prioritising public health guidance topics in the National Institute for Health and Care Excellence using the Analytic Hierarchy Process.
Reddy BP; Kelly MP; Thokala P; Walters SJ; Duenas A
Public Health; 2014 Oct; 128(10):896-903. PubMed ID: 25369354
[TBL] [Abstract][Full Text] [Related]
2. Multiple criteria decision analysis in the context of health technology assessment: a simulation exercise on metastatic colorectal cancer with multiple stakeholders in the English setting.
Angelis A; Montibeller G; Hochhauser D; Kanavos P
BMC Med Inform Decis Mak; 2017 Oct; 17(1):149. PubMed ID: 29073892
[TBL] [Abstract][Full Text] [Related]
3. Prioritisation for future surveillance, prevention and control of 98 communicable diseases in Belgium: a 2018 multi-criteria decision analysis study.
Klamer S; Van Goethem N; ; ; Thomas D; Duysburgh E; Braeye T; Quoilin S
BMC Public Health; 2021 Jan; 21(1):192. PubMed ID: 33482767
[TBL] [Abstract][Full Text] [Related]
4. Prioritizing investments in public health: a multi-criteria decision analysis.
Marsh K; Dolan P; Kempster J; Lugon M
J Public Health (Oxf); 2013 Sep; 35(3):460-6. PubMed ID: 23241415
[TBL] [Abstract][Full Text] [Related]
5. Prioritisation of specialist health care services; not NICE, not easy but it can be done.
Anderson P; Webb P; Groves S
Health Policy; 2017 Sep; 121(9):978-985. PubMed ID: 28797706
[TBL] [Abstract][Full Text] [Related]
6. The accountability problem of the National Institute for Health and Clinical Excellence.
Hasman A
Med Law; 2008 Mar; 27(1):83-93. PubMed ID: 18592883
[TBL] [Abstract][Full Text] [Related]
7. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
8. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
9. NICE methodological guidelines and decision making in the National Health Service in England and Wales.
Gafni A; Birch S; ;
Pharmacoeconomics; 2003; 21(3):149-57. PubMed ID: 12558466
[TBL] [Abstract][Full Text] [Related]
10. NICE at 10 years: new challenges ahead.
Littlejohns P
Expert Rev Pharmacoecon Outcomes Res; 2009 Apr; 9(2):151-6. PubMed ID: 19402803
[TBL] [Abstract][Full Text] [Related]
11. Pharmacopolitics and deliberative democracy.
Rawlins MD
Clin Med (Lond); 2005; 5(5):471-5. PubMed ID: 16268329
[TBL] [Abstract][Full Text] [Related]
12. Use of economic evaluation in local health care decision-making in England: a qualitative investigation.
Eddama O; Coast J
Health Policy; 2009 Mar; 89(3):261-70. PubMed ID: 18657336
[TBL] [Abstract][Full Text] [Related]
13. Evidence based public health: A review of the experience of the National Institute of Health and Clinical Excellence (NICE) of developing public health guidance in England.
Kelly M; Morgan A; Ellis S; Younger T; Huntley J; Swann C
Soc Sci Med; 2010 Sep; 71(6):1056-62. PubMed ID: 20678836
[TBL] [Abstract][Full Text] [Related]
14. Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): applying the EVIDEM framework to medicines appraisal.
Goetghebeur MM; Wagner M; Khoury H; Levitt RJ; Erickson LJ; Rindress D
Med Decis Making; 2012; 32(2):376-88. PubMed ID: 21987539
[TBL] [Abstract][Full Text] [Related]
15. Use of Expert Judgement Across NICE Guidance-Making Programmes: A Review of Current Processes and Suitability of Existing Tools to Support the Use of Expert Elicitation.
Peel A; Jenks M; Choudhury M; Lovett R; Rejon-Parrilla JC; Sims A; Craig J
Appl Health Econ Health Policy; 2018 Dec; 16(6):819-836. PubMed ID: 30073485
[TBL] [Abstract][Full Text] [Related]
16. The National Institute for Health and Clinical Excellence and its role in assessing the value of new cancer treatments in England and Wales.
Trowman R; Chung H; Longson C; Littlejohns P; Clark P
Clin Cancer Res; 2011 Aug; 17(15):4930-5. PubMed ID: 21791636
[TBL] [Abstract][Full Text] [Related]
17. Public health at National Institute for Health and Clinical Excellence (NICE) from 2012.
Kelly MP
Perspect Public Health; 2012 May; 132(3):111-3. PubMed ID: 22700573
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
